干扰素基因刺激蛋白信号通路与HBV感染的相互作用

许志强; 王晴; 潘修成

doi:10.3969/j.issn.1001-5256.2018.08.042

干扰素基因刺激蛋白信号通路与HBV感染的相互作用

DOI: 10.3969/j.issn.1001-5256.2018.08.042

徐州医科大学附属医院感染性疾病科

基金项目:

江苏省临床医学科技攻关专项(BL2012043)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2453
- HTML全文浏览量: 36
- PDF下载量: 405
- 被引次数: 0
出版历程
- 收稿日期: 2018-03-08
- 出版日期: 2018-08-20

Interaction between the stimulator of interferon genes signaling pathway and HBV

Department of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University

Research funding:

摘要

摘要: 干扰素基因刺激蛋白(STING)是新发现的天然免疫系统中的重要接头蛋白,在细胞质DNA介导天然免疫反应中发挥重要作用。胞内双链DNA识别受体均通过STING介导产生Ⅰ型干扰素以及其他细胞因子。天然免疫和抗HBV特异免疫应答不足是HBV慢性感染的关键原因。介绍了STING的发现及其结构研究的最新进展,并简要阐述了STING信号通路的活化机制。总结了国内外研究团队在STING信号通路与HBV相互作用方面的研究进展,并指出了其在临床治疗方面的潜在价值。
- 肝炎病毒,乙型 /
- 衔接蛋白质类,信号转导 /
- 免疫,天然 /
- 综述
Abstract: Stimulator of interferon genes ( STING) is a newly discovered adaptor protein in the innate immune system and plays an important role in innate immune response mediated by cytoplasmic DNA. Double-stranded DNA recognition receptors in cells are mediated by STING protein to produce type I interferon and other cytokines. Inadequate innate immune response and anti-hepatitis B virus ( HBV) specific immune response are important causes of chronic HBV infection. This article introduces the discovery of STING and the latest research advances in its structure, briefly elaborates on the mechanism of activation of the STING signaling pathway, summarizes the research advances in the interaction between the STING signaling pathway and HBV, and points out the potential value of STING in clinical treatment.
- hepatitis B virus /
- adaptor proteins, signal transducing /
- immunity, natural /
- review

HTML全文

参考文献(33)

[1]WANG Q, LIU J, YANG DL.Innate immune response and acquired immune response in patients with chronic HBV infection[J].J Clin Hepatol, 2016, 32 (10) :1863-1869. (in Chinese) 王琴, 刘嘉, 杨东亮.慢性HBV感染的天然免疫与获得性免疫应答[J].临床肝胆病杂志, 2016, 32 (10) :1863-1869.

[2]WU J, SUN L, CHEN X, et al.Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA[J].Science, 2013, 339 (6121) :827-830.

[3]NASSAL M.HBV ccc DNA:Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B[J].Gut, 2015, 64 (12) :1972-1984.

[4]HOLM CK, PALUDAN SR, FITZGERALD KA.DNA recognition in immunity and disease[J].Curr Opin Immunol, 2013, 25 (1) :13-18.

[5]SAUER JD, SOTELOTROHA K, VON MJ, et al.The N-ethylN-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides[J].Infect Immun, 2011, 79 (2) :688-694.

[6]BURDETTE DL, MONROE KM, SOTELOTROHA K, et al.STING is a direct innate immune sensor of cyclic-di-GMP[J].Nature, 2011, 478 (7370) :515-518.

[7]CONLON J, BURDETTE DL, SHARMA S, et al.Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5, 6-dimethylxanthenone-4-acetic acid[J].J Immunol, 2013, 190 (10) :5216-5225.

[8]TANER C, TOBIAS D, ABLASSER A, et al.Species-specific detection of the antiviral small-molecule compound CMA by STING[J].EMBO J, 2013, 32 (10) :1440-1450.

[9]CIVRIL F, DEIMLING T, de OLIVEIRA MANN CC, et al.Structural mechanism of cytosolic DNA sensing by c GAS[J].Nature, 2013, 498 (7454) :332-337.

[10]CAI X, CHIU YH, CHEN ZJ.The c GAS-c GAMP-STING pathway of cytosolic DNA sensing and signaling[J].Mol Cell, 2014, 54 (2) :289-296.

[11]KIM S, LI L, MALIGA Z, et al.Anticancer flavonoids are mouse-selective STING agonists[J].ACS Chem Biol, 2013, 8 (7) :1396-1401.

[12]CHIN KH, TU ZL, SU YC, et al.Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING[J].Acta Crystallogr D Biol Crystallogr, 2013, 69 (Pt 3) :352-366.

[13]OUYANG S, SONG X, WANG Y, et al.Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding[J].Immunity, 2012, 36 (36) :1073-1086.

[14]SHU C, YI G, WATTS T, et al.Structure of STING bound to cdi-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system[J].Nat Struct Mol Biol, 2012, 19 (7) :722-724.

[15]ELIE J, DINER, DARA L, et al.The innate immune DNA sensor c GAS produces a non-canonical cyclic-di-nucleotide that activates human STING[J].Cell Rep, 2013, 3 (5) :1355-1361.

[16]ZHANG X, SHI H, WU J, et al.Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high affinity ligand for STING[J].Mol Cell, 2015, 51 (2) :226-235.

[17]BARKER JR, KOESTLER BJ, CARPENTER VK, et al.STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during chlamydia trachomatis infection[J].MBio, 2013, 4 (3) :e00018-13.

[18]WIELAND S, THIMME R, PURCELL RH, et al.Genomic analysis of the host response to hepatitis B virus infection[J].Proc Natl Acad Sci U S A, 2004, 101 (17) :6669-6674.

[19]WIELAND SF, CHISARI FV.Stealth and cunning:Hepatitis B and hepatitis C viruses[J].J Virol, 2005, 79 (15) :9369-9380.

[20]CHRISTEN V, DUONG F, BERNSMEIER C, et al.Inhibition of alpha interferon signaling by hepatitis B virus[J].J Virol, 2007, 81 (1) :159-165.

[21]VISVANATHAN K, SKINNER NA, THOMPSON AJ, et al.Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein[J].Hepatology, 2007, 45 (1) :102-110.

[22]CHEN Z, CHENG Y, XU Y, et al.Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients[J].Clin Immunol, 2008, 128 (3) :400-408.

[23]OLIVIERO B, VARCHETTA S, PAUDICE E, et al.Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections[J].Gastroenterology, 2009, 137 (3) :1151-1160.

[24]GUO F, HAN Y, ZHAO X, et al.STING agonists induce an innate antiviral immune response against hepatitis B virus[J].Antimicrob Agents Chemother, 2015, 59 (2) :1273-1281.

[25]DANSAKO H, UEDA Y, OKUMURA N, et al.The cyclic GMPAMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly[J].FEBS J, 2016, 283 (1) :144-156.

[26]GAO D, WU J, WU YT, et al.Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses[J].Science, 2013, 341 (6148) :903-906.

[27]LIU Y, LI J, CHEN J, et al.Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways[J].J Virol, 2014, 89 (4) :2287-2300.

[28]YIM SA, HEYDMANN L, VERRIER E, et al.The CGAS-sting pathway exhibits antiviral activity against hepatitis B virus infection[J].J Hepatol, 2016, 64 (2) :s396.

[29]HE J, HAO R, LIU D, et al.Inhibition of hepatitis B virus replication by activation of the c GAS-STING pathway[J].J Gen Virol, 2016, 97 (12) :3368-3378.

[30]HOSEL M, QUASDORFF M, WIEGMANN K, et al.Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection[J].Hepatology, 2009, 50 (6) :1773-1782.

[31]LIU Y, LI J, CHEN J, et al.Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways[J].J Virol, 2015, 89 (4) :2287-2300.

[32]THOMSEN MK, NANDAKUMAR R, STADLER D, et al.Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection[J].Hepatology, 2016, 64 (3) :746-759.

[33]LI FL, HUA J, LU YP, et al.Research advances in innate immunity against hepatitis B virus[J].J Clin Hepatol, 2016, 32 (5) :992-996. (in Chinese) 李凤莉, 华娟, 卢银平, 等.HBV感染天然免疫的研究进展[J].临床肝胆病杂志, 2016, 32 (5) :992-996.

施引文献

资源附件(0)

访问统计